학술논문

De Novo HER2 S310Y mutation associates with poor response to EGFR tyrosine kinase inhibitor in activating EGFR-mutant NSCLC patient: A case report
Document Type
Journal
Source
EUROPEAN JOURNAL OF INFLAMMATION; FEB 2019, 17 p2058739219827166 6p.
Subject
Language
English
ISSN
20587392